Gastrointestinal Disorder (GI) & Medical Marijuana

 

Gastrointestinal diseases are a group of disorders of the gastrointestinal tract, including esophagus, stomach, small and large intestines and rectum.  Supporting digestive organs include the liver, gallbladder, and pancreas.  The cause of gastrointestinal distresses include food intolerance, bad diet, bacterial imbalance in the gut, infection, cancer and organ dysfunction.

 

• Half the world's population has GI yearly !!
• 10% of cases are debilitating for one week or more
• Second most common cause of death in children
• The most common cause of malnutrition
• Cannabis was used for centuries to treat GI symptoms

 

"It is still just unbelievable to us that diarrhea is one of the leading causes of child deaths in the world."

--  Melinda Gates, Gates Foundation

 

Symptoms commonly include; nausea, stomach and intestinal pain, gassiness, loss of appetite, bloating, constipation, diarrhea, abdominal cramping, fever, racing pulse.

 

Cannabinoids, the active ingredients in Medical Marijuana and derivatives, are commonly indicated in the treatment of every GI symptom listed (above), especially for pain and inflammation.  Certainly, in the cases of serious bacterial infections, other medications are commonly used as well.

 

 

Medical Marijuana History -  Always a Remedy for GI - Until 1930's BAN

Medical Marijuana (MMJ) was commonly used as a folk remedy throughout the world to treat pain and inflammation, among many other disorders. Only, in the last century, has the use of MMJ been discouraged.  In the United States, up until the 1930's, Medical Cannabis products were prescribed as a pharmaceutical for many disorders, including GI.  Over the past few decades, many research studies and clinical trials worldwide have overwhelming shown that MMJ is a powerful drug, useful in the treatment of many conditions including Gastrointestinal Disorders.

 

 

Further Reading

Cannabis Shown have a 90% Positive CLINICAL Response Rate

THC-rich Medical Cannabis produced significant clinical, steroid-free benefits to 10 of 11 patients with active Crohn's disease, compared with placebo, without side effects.  Patient symptom relief includes abdominal pain, nausea, flatulence, unexpected bowel movement.

--  Department of Gastroenterology and Hepatology, Meir Medical Center and Sackler Faculty of Medicine, Tel Aviv University

 

Most Patients with Inflammatory Bowel Disease Benefit from Medical Marijuana

In this study, most patients find MMJ to be very helpful to reduce pain, inflammation, ease digestion and other symptoms in GI, especially ulcerative colitis.

--  Division of Gastroenterology, Hepatology and Endoscopy,  Department of Medicine, Brigham and Women's Hospital, Boston, Mass.

 

Cannabis Improves Quality of Life in GI Patients.  Promotes Healing.

In this study Medical Cannabis was found to improve the quality of life in GI patients.  The patient's overall gained weight and many experienced an improvement in the underlying disorders that caused the GI condition.

--  Sackler School of Medicine, Tel Aviv University, Israel

 

MAYO Clinic - Medical Cannabis Ingredient, THC relieves Serious Chronic Diarrhea

These researchers found that certain types of patients benefited most from MMJ in the treatment of Diarrhea.  Genetics are suspected to play a part and further study is warranted to further refine methods of Cannabinoid therapy.

--  Clinical Enteric Neuroscience Translational and Epidemiological Research, Mayo Clinic, Rochester, Minnesota, USA.

 

Cannabis Commonly used in GI for Symptom Relief

This study found that Cannabis use was common amongst patients with IBD for symptom relief, especially in those with abdominal surgery, chronic abdominal pain and low quality of life index. Therapeutic benefits of cannabinoid derivatives merit further exploration.

--  The IBD Clinic, Mount Sinai Hospital, Toronto, Ontario, Canada

 

Cannabinoid, THC Reduced Abnormal Colon Dumping

In this Pharmacogenetic Trial, THC, a component of Medical Cannabis l reduces fasting motility of the colon with Non-Constipated Irritable Bowel Syndrome.

--  Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Rochester, Minnesota.

 

 

As seen on https://mmjdoctoronline.com